Hercules

BIOLOGICAL2 trials

Sponsors

Mylan Pharmaceuticals Inc, Faculty of Pharmacy, Alexandria university

Conditions

Erectile DysfunctionHealthy

Phase 1

Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion

CompletedNCT02594761

Mylan Pharmaceuticals IncHealthy

Start: 2013-08-31End: 2014-02-28Updated: 2015-11-03

Unknown Phase

Male enhancement nutraceuticals evaluation in Egypt

Active, not recruitingPACTR201505001128346

Faculty of Pharmacy, Alexandria universityErectile Dysfunction

Start: 2014-09-01Target: 50Updated: 2026-08-03

Related Papers

A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL‐1401O <i>vs</i>. EU‐trastuzumab and US‐trastuzumab

British Journal of Clinical Pharmacology2018-06-2129 citations

A pharmacokinetics (PK) bioequivalence trial of proposed trastuzumab biosimilar, Myl-1401O (A) vs EU-Herceptin (B) and US-Herceptin (C).

Journal of Clinical Oncology2016-05-205 citations